2020 KDA/KSN共识声明：钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用

2020-08-30 韩国糖尿病协会 Diabetes Metab J.2020 Aug;44(4):489-497.

2020年8月，韩国糖尿病协会(KDA)联合韩国肾脏病学会(KSN)共同发布了钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用的共识声明。糖尿病时终末期肾病的主要原因，因袭，

中文标题：

英文标题：

Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement

发布机构：

韩国糖尿病协会

发布日期：

2020-08-30

简要介绍：

2020年8月，韩国糖尿病协会(KDA)联合韩国肾脏病学会(KSN)共同发布了钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用的共识声明。糖尿病时终末期肾病的主要原因，因袭，预防肾功能不全是糖尿病治疗的重要目标。本文主要针对钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用提供共识声明建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=d57091c00196862e, title=2020 KDA/KSN共识声明：钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用, enTitle=Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement, guiderFrom=Diabetes Metab J.2020 Aug;44(4):489-497., authorId=0, author=, summary=2020年8月，韩国糖尿病协会(KDA)联合韩国肾脏病学会(KSN)共同发布了钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用的共识声明。糖尿病时终末期肾病的主要原因，因袭，, cover=https://img.medsci.cn/2020910/1599671648109_2020535.jpg, journalId=0, articlesId=null, associationId=1536, associationName=韩国糖尿病协会, associationIntro=, copyright=0, guiderPublishedTime=Sun Aug 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，韩国糖尿病协会(KDA)联合韩国肾脏病学会(KSN)共同发布了钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用的共识声明。糖尿病时终末期肾病的主要原因，因袭，预防肾功能不全是糖尿病治疗的重要目标。本文主要针对钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用提供共识声明建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=2052, tagName=2型糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2052, guiderKeyword=2型糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4496, appHits=183, showAppHits=0, pcHits=421, showPcHits=4313, likes=4, shares=14, comments=12, approvalStatus=1, publishedTime=Thu Sep 10 01:37:10 CST 2020, publishedTimeString=2020-08-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 10 01:13:14 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 13:31:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 KDA_KSN共识声明.pdf)])

2020 KDA_KSN共识声明.pdf

下载请点击：

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1051922, encodeId=4505105192266, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10d5528657, createdName=ms4000001647958285, createdTime=Thu Sep 16 12:19:11 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950526, encodeId=1bac9505268f, content=<a href='/topic/show?id=c885103940e0' target=_blank style='color:#2F92EE;'>#SGLT2i类#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103940, encryptionId=c885103940e0, topicName=SGLT2i类)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Mar 23 23:07:15 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948568, encodeId=f8bf9485680d, content=SGLT2药物对肾脏保护作用及eGFR使用切点为关注问题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e02098808, createdName=ms6979315883460749, createdTime=Tue Mar 16 08:59:14 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917356, encodeId=833c91e35648, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:37 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891645, encodeId=de388916457a, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f975307753, createdName=1487e47cm48暂无昵称, createdTime=Mon Oct 12 23:04:14 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2021-09-16 ms4000001647958285

太好了

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1051922, encodeId=4505105192266, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10d5528657, createdName=ms4000001647958285, createdTime=Thu Sep 16 12:19:11 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950526, encodeId=1bac9505268f, content=<a href='/topic/show?id=c885103940e0' target=_blank style='color:#2F92EE;'>#SGLT2i类#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103940, encryptionId=c885103940e0, topicName=SGLT2i类)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Mar 23 23:07:15 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948568, encodeId=f8bf9485680d, content=SGLT2药物对肾脏保护作用及eGFR使用切点为关注问题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e02098808, createdName=ms6979315883460749, createdTime=Tue Mar 16 08:59:14 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917356, encodeId=833c91e35648, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:37 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891645, encodeId=de388916457a, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f975307753, createdName=1487e47cm48暂无昵称, createdTime=Mon Oct 12 23:04:14 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2021-03-23 病毒猎手

#SGLT2i类#

101 0
[GetPortalCommentsPageByObjectIdResponse(id=1051922, encodeId=4505105192266, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10d5528657, createdName=ms4000001647958285, createdTime=Thu Sep 16 12:19:11 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950526, encodeId=1bac9505268f, content=<a href='/topic/show?id=c885103940e0' target=_blank style='color:#2F92EE;'>#SGLT2i类#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103940, encryptionId=c885103940e0, topicName=SGLT2i类)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Mar 23 23:07:15 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948568, encodeId=f8bf9485680d, content=SGLT2药物对肾脏保护作用及eGFR使用切点为关注问题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e02098808, createdName=ms6979315883460749, createdTime=Tue Mar 16 08:59:14 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917356, encodeId=833c91e35648, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:37 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891645, encodeId=de388916457a, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f975307753, createdName=1487e47cm48暂无昵称, createdTime=Mon Oct 12 23:04:14 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2021-03-16 ms6979315883460749

SGLT2药物对肾脏保护作用及eGFR使用切点为关注问题

58 0
[GetPortalCommentsPageByObjectIdResponse(id=1051922, encodeId=4505105192266, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10d5528657, createdName=ms4000001647958285, createdTime=Thu Sep 16 12:19:11 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950526, encodeId=1bac9505268f, content=<a href='/topic/show?id=c885103940e0' target=_blank style='color:#2F92EE;'>#SGLT2i类#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103940, encryptionId=c885103940e0, topicName=SGLT2i类)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Mar 23 23:07:15 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948568, encodeId=f8bf9485680d, content=SGLT2药物对肾脏保护作用及eGFR使用切点为关注问题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e02098808, createdName=ms6979315883460749, createdTime=Tue Mar 16 08:59:14 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917356, encodeId=833c91e35648, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:37 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891645, encodeId=de388916457a, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f975307753, createdName=1487e47cm48暂无昵称, createdTime=Mon Oct 12 23:04:14 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2021-01-17 黄伟医生

好

91 0
[GetPortalCommentsPageByObjectIdResponse(id=1051922, encodeId=4505105192266, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b10d5528657, createdName=ms4000001647958285, createdTime=Thu Sep 16 12:19:11 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950526, encodeId=1bac9505268f, content=<a href='/topic/show?id=c885103940e0' target=_blank style='color:#2F92EE;'>#SGLT2i类#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103940, encryptionId=c885103940e0, topicName=SGLT2i类)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Mar 23 23:07:15 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948568, encodeId=f8bf9485680d, content=SGLT2药物对肾脏保护作用及eGFR使用切点为关注问题, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85e02098808, createdName=ms6979315883460749, createdTime=Tue Mar 16 08:59:14 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917356, encodeId=833c91e35648, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/b09fbd886f1e4431b94c8ca932de8daf/7a5fb5dcd8164cd6a2ab2c04b8ecc21f.jpg, createdBy=f75f2321812, createdName=黄伟医生, createdTime=Sun Jan 17 10:23:37 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891645, encodeId=de388916457a, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f975307753, createdName=1487e47cm48暂无昵称, createdTime=Mon Oct 12 23:04:14 CST 2020, time=2020-10-12, status=1, ipAttribution=)]
2020-10-12 1487e47cm48暂无昵称

👍

112 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌科指南

2020 KDA/KSN共识声明：钠葡萄糖共转运蛋白2抑制剂(SGLT2i)对2型糖尿病患者肾功能的保护作用

相关指南

拓展阅读

科室

工具

服务